Dyshidrosiform pemphigoid induced by ustekinumab in a patient with ulcerative colitis

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e160-e162. doi: 10.1111/jdv.18686. Epub 2022 Oct 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Pemphigoid, Bullous* / chemically induced
  • Ustekinumab / adverse effects

Substances

  • Ustekinumab